News and reflections from the world of AI

    March 16, 2021

    Validation of PD-L1 AI model launches in six labs across the Netherlands

    Introduction  Programmed death-ligand 1 (PDL1) is a protein that, when attached to T cells, prevent the immune system from killing cancer cells. Hence, PDL1 is used as a biomarker for tumor immune escape, a sign of increasing cancer progression. PDL1 percentage is also a significant predictor for immunotherapy efficacy, whereby immune checkpoint inhibitors bind to PDL1 and block its ability to ...
    Written by Aiforia
    February 4, 2021

    DECIDER project launches to improve diagnostics and treatment of ovarian cancer

    The European Union has funded a project to improve personalized treatments for ovarian cancer with nearly 15 million euros for five years. The international DECIDER project has partners from 14 organizations in seven EU countries.
    Written by Aiforia
    October 9, 2020

    Interview with Kevin Sandeman: driving one of the world’s largest digital transformations in pathology

    Skåne, a southern county of Sweden, recently completed one of the largest adoptions of digital pathology in the world. Four labs, 14 scanners, and an estimated 890,746 slides were used and scanned from May 2019 to July 2020.  At the helm of this feat, pushing forward the digitization of these pathology labs, is Kevin Sandeman. We interviewed him to hear about the process of going digital, what ...
    Written by Aiforia
    September 1, 2020

    €2.1M EU funding takes Aiforia to the clinic

        Supporting pathologists in cancer diagnostics The €2.1M funding was awarded to Aiforia Technologies as part of the European Union’s Horizon 2020 research and innovation programme and enables the health tech company to launch itself into the diagnostics space. Aiforia’s vision is that AI will become a mandatory tool for doctors, soon a visual diagnosis will not be made without the assistance ...
    Written by Aiforia
    1 2